Cargando…
MON-030 Intermediate Hyperglycemia and Type 2 Diabetes in Women with Polycystic Ovary Syndrome: Findings from Large Caucasian Cohort
Background: Insulin secretory defects and insulin resistance exists in women with polycystic ovary syndrome (PCOS) and are prerequisites for the development of type 2 diabetes (T2D). Objective: To determine the prevalence of T2D, impaired glucose tolerance (IGT) and impaired fasting glucose (IFG), a...
Autores principales: | Livadas, Sarantis, Bothou, Christina, Kuliczkowska-Płaksej, Justyna, Androulakis, Ioannis, Robeva, Ralitsa, Vryonidou, Andromahi, Macut, Jelica Bjekic, Mouslech, Zadalla, Milewicz, Andrzej Jan, Panidis, Dimitrios, Macut, Djuro P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207502/ http://dx.doi.org/10.1210/jendso/bvaa046.1202 |
Ejemplares similares
-
MON-214 The Natural Course of Normal Weight Women with Polycystic Ovary Syndrome: An Insight into Metabolic Changes of Large Caucasian Cohort
por: Livadas, Sarantis, et al.
Publicado: (2019) -
Can dysglycemia in OGTT be predicted by baseline parameters in patients with PCOS?
por: Livadas, Sarantis, et al.
Publicado: (2022) -
Assessment of Type 2 Diabetes Risk in Young Women with Polycystic Ovary Syndrome
por: Livadas, Sarantis, et al.
Publicado: (2023) -
Metabolic Perspectives for Non-classical Congenital Adrenal Hyperplasia With Relation to the Classical Form of the Disease
por: Macut, Djuro, et al.
Publicado: (2019) -
Editorial: Congenital Adrenal Hyperplasia, Unresolved Issues and Implications on Clinical Management
por: Livadas, Sarantis, et al.
Publicado: (2020)